Finance

Beta
Lists
300233:SHE
Shandong Jincheng Pharmacetcl Grp Co Ltd
CN¥12.66
+1.12%
(+0.14) 1D
Jun 5, 3:04:55 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300233...
Open
CN¥12.58
High
CN¥12.89
Low
CN¥12.50
Mkt. cap
4.81B
Avg. vol.
9.00M
Volume
6.01M
Dividend
1.97%
Quarterly dividend
CN¥0.06
Ex-dividend date
May 15, 2026
P/E ratio
68.45
52-wk high
CN¥22.47
52-wk low
CN¥12.42
EPS
CN¥0.18
Shares outstanding
383.87M
No. of employees
4K
Open
CN¥12.58
High
CN¥12.89
Low
CN¥12.50
Mkt. cap
4.81B
Avg. vol.
9.00M
Volume
6.01M
Dividend
1.97%
Quarterly dividend
CN¥0.06
Ex-dividend date
May 15, 2026
P/E ratio
68.45
52-wk high
CN¥22.47
52-wk low
CN¥12.42
EPS
CN¥0.18
Shares outstanding
383.87M
No. of employees
4K
News stories
From sources across the web
About Shandong Jincheng Pharmacetcl Grp Co Ltd
CEO-
Employees3.52K
FoundedJan 12, 2004
Headquarters-
SectorPharmaceutical industry
Websitejinchengpharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
638.32M
571.78M
804.90M
750.42M
Cost of goods sold
421.04M
335.86M
580.35M
490.69M
Cost of revenue
421.04M
335.86M
580.35M
490.69M
Research and development expenses
41.08M
37.92M
76.63M
37.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
163.97M
188.66M
101.14M
131.61M
Operating expense
217.98M
214.54M
211.31M
174.47M
Total operating expenses
639.02M
550.40M
791.65M
665.16M
Operating income
-698.42K
21.39M
13.25M
85.27M
Other non operating income
2.06M
-2.75M
2.32M
-3.24M
EBT including unusual items
9.98M
-9.21M
27.44M
76.16M
EBT excluding unusual items
2.03M
15.96M
15.75M
81.89M
Income tax expense
1.32M
2.16M
18.77M
17.15M
Effective tax rate
13.20%
-23.47%
68.39%
22.51%
Other operating expenses
10.70M
-4.63M
20.94M
4.07M
Net income
8.33M
-11.81M
12.61M
57.79M
Net profit margin
1.30%
-2.06%
1.57%
7.70%
Earnings per share
-
-
-
-
Interest and investment income
1.68M
1.48M
2.99M
1.86M
Interest expense
-2.69M
-2.47M
-2.29M
-1.99M
Net interest expenses
-1.01M
-992.40K
707.51K
-131.57K
Depreciation and amortization charges
-
-
-
-
EBITDA
77.45M
100.60M
93.00M
165.01M
Gain or loss from assets sale
-388.85K
388.85K
-2.95M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer